Drug Trial Radar · NCT00088452
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
Last checked: Nov 20, 2026Latest source record: Oct 14, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
453
Actual
Start
Jul 2004
Primary completion
Jan 2013
Study completion Aug 31, 2016
Sponsor
- Lead sponsor
- Children's Hospital Medical Center, CincinnatiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Neurological Disorders and Stroke (NINDS)
- First posted
- Jul 27, 2004
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 months, up to 13 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
Conditions
- Childhood Absence Epilepsy
- Petit Mal Epilepsy
- Epilepsy
- Seizures
Interventions
EthosuximideDrug
Ethosuximide is a common treatment for childhood absence epilepsy.
LamotrigineDrug
Lamotrigine is a common treatment for childhood absence epilepsy.
Valproic acidDrug
Valproic acid is a common treatment for childhood absence epilepsy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Freedom From Treatment Failure at 16-20 Weeks of Double Blind TherapyTime frame: First 16-20 weeks of double blind therapy
Locations
31 sites in 1 country. Site status is shown where the registry gives one.
The Children's Hospital of Alabama
Birmingham, Alabama
St. Joseph's Hospital and Medical Center
Phoenix, Arizona
Arkansas Children's Hospital
Little Rock, Arkansas
University of California at San Diego
La Jolla, California
Mattel Children's Hospital at UCLA
Los Angeles, California
Children's Hospital of Denver
Denver, Colorado
Yale University School of Medicine
New Haven, Connecticut
Children's National Medical Center
Washington D.C., District of Columbia
Nemours Children's Clinic
Jacksonville, Florida
Miami Children's Hospital
Miami, Florida
Children's Healthcare of Atlanta
Atlanta, Georgia
Children's Memorial Hospital
Chicago, Illinois
Children's Hospital of Michigan
Detroit, Michigan
Washington University in St. Louis
St Louis, Missouri
Women and Children's Hospital of Buffalo
Buffalo, New York
NYU Comprehensive Epilepsy Center, Manhattan
New York, New York
Montefiore Medical Center
The Bronx, New York
Cincinnati Children's Hospital
Cincinnati, Ohio
Rainbow Babies & Children's Hospital
Cleveland, Ohio
Children's Hospital, Inc., PCTI
Columbus, Ohio
Doernbecher Children's Hospital
Portland, Oregon
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
LeBonheur Children's Medical Center
Memphis, Tennessee
Dallas Pediatric Neurology Associates
Dallas, Texas
Cook Children's Medical Center
Fort Worth, Texas
Texas Children's Hospital
Houston, Texas
University of Utah/Primary Children's Medical Center
Salt Lake City, Utah
Children's Hospital of The King's Daughter (Monarch Medical Research)
Norfolk, Virginia
Children's Hospital & Regional Medical Center
Seattle, Washington
Children's Hospital of Wisconsin
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.